Document is current
Any future updates will be listed below
-
Authors
Ayas, Najib T.
Jen, Rachel
Baumann, Brett
- License Information
-
More Information
Article History
Received: 22 January 2021
Accepted: 28 May 2021
First Online: 15 July 2021
Declarations
:
: N/A (not applicable).
: N/A.
: NA has received funding from Signifier Technologies for a research project (clinical trial of an OSA treatment). He is on the scientific advisory board of Bresotec (makes a LIII ambulatory device for OSA) but has not received funding from them since 2017. His post-doctoral fellow is partially supported by a Mitacs fellowship (partnered with Cerebra that makes a variety of products including LII devices). He is an Associate Editor for the AJRCCM and receives an honorarium for this. RJ and BB declare they have no competing interests.
